captopril has been researched along with Heart Disease, Ischemic in 59 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 36 (61.02) | 18.2507 |
| 2000's | 19 (32.20) | 29.6817 |
| 2010's | 3 (5.08) | 24.3611 |
| 2020's | 1 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Ambrosio, G; Borghi, C; Mancia, G; Van De Borne, P | 1 |
| Akhtar, S; Al-Rashdan, I; Babiker, F; Benter, IF; Yousif, M | 1 |
| Dralova, OV; Ermolaeva, AS; Maksimov, ML | 1 |
| Chen, JB; Huang, CX; Sun, XM | 1 |
| Irigoyen, MC; Kucharski, LC; Machado, UF; Oliveira, AR; Oliveira, UO; Schaan, BD | 1 |
| Frascarelli, S; Ghelardoni, S; Ronca-Testoni, S; Zucchi, R | 1 |
| Evdokimova, AG; Kovalenko, EV; Pichugina, TA; Radzevich, AE; Tereshchenko, OI | 1 |
| Borghi, C; Cosentino, E; De Sanctis, D | 1 |
| Dem'iankova, IuO; Kratnov, AA; Kratnov, AE; Popov, SA | 1 |
| Danser, AH; Krop, M; van Esch, JH | 1 |
| Buikema, H | 1 |
| Ambrosioni, E | 1 |
| Abete, P; Acanfora, D; Ferrara, N; Furgi, G; Guerra, N; Leosco, D; Longobardi, G; Nicolino, A; Papa, A; Rengo, F | 1 |
| Eng, C; Sonnenblick, EH; Weil, BJ | 1 |
| Xu, SC; Zhang, YH | 1 |
| Kanno, M; Kitabatake, A; Kohya, T; Nakaya, H; Saito, H; Tohse, N; Yokoshiki, H | 1 |
| Kalashnikov, VF; Sinopal'nikov, VI | 1 |
| Davis, BR; Flaker, GC; Kowey, PR; Lamas, GA; Miller, HS; Moyé, LA; Packer, M; Pfeffer, MA; Rouleau, JL; Rutherford, JD | 1 |
| Bastrukov, AI | 1 |
| Altieri, PI; Banchs, HL; Méndez, H; Silva, W | 1 |
| Yokoshiki, H | 1 |
| Berrazueta, JR; Ochoteco, A; Poveda Sierra, JJ; Salas, E | 1 |
| Cheltsov, VV; Moiseev, VS; Shatkovskiĭ, NP | 1 |
| Gøtzsche, CO; Nøgaard, A; Ravkilde, J; Søgaard, P; Thygesen, K | 1 |
| Battler, A; Leor, J; Varda-Bloom, N | 1 |
| Anguita, M; Arizón, JM; Bueno, G; Concha, M; Giménez, D; Latre, JM; Sancho, M; Torres, F; Vallés, F | 1 |
| Kozyreva, MP; Martsevich, SIu; Metelitsa, VI; Vakulovskaia, MK | 1 |
| Klaus, W; Korth, A; Rösen, R; Rump, AF | 1 |
| Abe, M; Haneda, T; Okamoto, K | 1 |
| Gøtzsche, CO; Ravkilde, J; Søgaard, P; Thygesen, K | 1 |
| Antonaccio, MJ; Dzwonczyk, S; Grover, GJ; Normandin, D; Sargent, CA; Sleph, PG; Smith, MA | 1 |
| McTavish, D; Plosker, GL | 1 |
| Berglund, G; Boström, PA; Diemer, H; Lilja, B; Mansour, P; Mattiasson, I; Nehoum, A | 1 |
| Ahmad, M; Parratt, JR; Zeitlin, IJ | 1 |
| Riva, E; Traquandi, C | 1 |
| Arata, H; Geshi, E; Ishioka, H; Itoh, S; Katagiri, T; Konno, N; Mukae, S; Tomita, M; Yanagishita, T | 1 |
| Arabidze, GG; Filatova, EV; Kukharchuk, VV; Rogoza, AN; Vikhert, OA | 1 |
| de Vries, RJ; Dunselman, PH; Kingma, JH; van den Heuvel, AF; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Alföldi, S | 1 |
| Demircin, M; Doğan, R; Farsak, B; Isbir, S; Kilinç, K; Sarigül, A; Tuncer, M | 1 |
| Amy, RM; Dolphin, PJ; Graham, SE; Russell, JC | 1 |
| Black, SC; Driscoll, EM; Lucchesi, BR | 1 |
| Antunes, AM; Branco, L; do Rosário, L; Ferreira, L; Ferreira, R; Martins, S; Oliveira, M; Ramos, S; Sequeira, A; Soares, RM; Sousa, L; Sousa, MJ | 1 |
| Gallois, H; Haïat, R; Hanania, G; Piot, O | 1 |
| Guo, X; Luo, A; Wang, M; Xu, S; Zhao, X | 1 |
| Gould, RJ; Grossman, W; Kusma, SE; Lynch, JJ; Painter, CA; Stump, GL; Thomas, JM; Wallace, AA | 1 |
| Beresewicz, A; Maczewski, M | 1 |
| Luft, FC | 1 |
| Menshikova, EV; Salama, G | 1 |
| Filipiak, J; Ozegowski, S; Poprawski, K; Sieńko, A; Szymanowska, K; Wierzchowiecki, M | 1 |
| Chernin, G; George, J; Greenberg, S; Keren, G; Laniado, S; Shapira, I; Wollman, Y | 1 |
| Brunner, HR; Gavras, H | 1 |
| Alfimova, TV; Gapon, LI; Gul'tiaeva, EP; Shafer, MZh | 1 |
| Andrejak, M; Fournier, A; Mazouz, H; Monge, M; Oprisiu, R | 1 |
| Divisová, J; Drahota, Z; Kazdová, L; Stopka, P; Tutterová, M; Vavrínková, H | 1 |
| Akhmetova, AS; Teĭblium, MM; Zaslavskaia, RM; Zhamankulov, KZh | 1 |
| Felder, RB; Francis, J; Weiss, RM; Zhang, ZH | 1 |
| Boraso, A; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Visioli, O | 1 |
| Averbuch, M; Finkelstein, A; Greenland, M; Kornowski, R; Lehrman, H; Levo, Y; Pines, A; Schwartz, D | 1 |
10 review(s) available for captopril and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Modem inhibitor angiotensin-converting enzyme zofenopril in the primary and secondary prevention of cardiovascular disease].
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Clinical Trials as Topic; Humans; Hypertension; Myocardial Ischemia; Outcome Assessment, Health Care; Renin-Angiotensin System | 2014 |
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Captopril; Cardiovascular Diseases; Enalapril; Heart Failure; Humans; Hypertension; Myocardial Infarction; Myocardial Ischemia; Renin-Angiotensin System; Ventricular Dysfunction | 2005 |
Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Captopril; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; History, 19th Century; History, 20th Century; Humans; Myocardial Infarction; Myocardial Ischemia | 2006 |
Defining the role of zofenopril in the management of hypertension and ischemic heart disorders.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Drug Administration Schedule; Humans; Hypertension; Myocardial Ischemia; Treatment Outcome | 2007 |
[Captopril: a new drug for myocardial ischemia and infarction?].
Topics: Captopril; Humans; Myocardial Infarction; Myocardial Ischemia | 1993 |
[The use of angiotensin-converting enzyme inhibitors in patients with ischemic heart disease].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Captopril; Drug Evaluation; Enalapril; Humans; Hypertension; Myocardial Ischemia | 1993 |
Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Myocardial Infarction; Myocardial Ischemia | 1995 |
[Use of captopril in therapeutic combinations].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Myocardial Ischemia | 1997 |
STOPPING at the CAPPP of good HOPE.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Diuretics; Drug Therapy, Combination; Heart Failure; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Ischemia; Randomized Controlled Trials as Topic; Stroke; Treatment Outcome | 2000 |
Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Captopril; Clinical Trials as Topic; Coronary Circulation; Heart Failure; Hemodynamics; Humans; Hypertension; Male; Myocardial Ischemia; Renin; Renin-Angiotensin System; Saralasin; Teprotide | 2001 |
14 trial(s) available for captopril and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Nebivolol in the treatment of ischemic heart disease patients with chronic heart failure].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzopyrans; Captopril; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Nebivolol; Treatment Outcome | 2004 |
[Lisinopril-induced changes in antioxidant defense in patients with acute coronary syndrome and concomitant diabetes mellitus type 2].
Topics: Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Catalase; Diabetes Mellitus, Type 2; Disease Progression; Female; Follow-Up Studies; Glutathione Reductase; Humans; Lisinopril; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Oxidative Stress; Oxidoreductases; Peroxidase; Severity of Illness Index; Spectrophotometry; Superoxide Dismutase; Treatment Outcome | 2005 |
Failure of protective effect of captopril and enalapril on exercise and dipyridamole-induced myocardial ischemia.
Topics: Adult; Aged; Angina Pectoris; Captopril; Cross-Over Studies; Dipyridamole; Double-Blind Method; Echocardiography; Enalapril; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Failure | 1995 |
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.
Topics: Angina, Unstable; Captopril; Cardiomegaly; Double-Blind Method; Hospitalization; Humans; Incidence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Placebos; Recurrence; Risk Factors; Survival Analysis | 1994 |
Transient elevation of pulmonary arterial pressure induced by sublingual angiotensin converting enzyme inhibitors.
Topics: Administration, Sublingual; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Cardiac Catheterization; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Pulmonary Artery; Vascular Resistance | 1994 |
[Does captopril possess antianginal actions? An evaluation of its effects on myocardial ischemia by stress tests in patients with stable angina and normal ventricular function].
Topics: Adult; Aged; Angina Pectoris; Captopril; Exercise Test; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Ventricular Function, Left | 1993 |
[Differential use of vasodilators in various types of cardiac insufficiency].
Topics: Adult; Aged; Blood Pressure; Captopril; Cardiomyopathy, Dilated; Female; Humans; Hypertension; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Nifedipine; Stroke Volume | 1993 |
Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction.
Topics: Captopril; Cardiac Volume; Double-Blind Method; Electrocardiography; Female; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Recurrence; Ultrasonography; Ventricular Function, Left | 1994 |
Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction.
Topics: Captopril; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Ventricular Function, Left | 1993 |
Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Substance Withdrawal Syndrome | 1997 |
Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Echocardiography; Female; Heart Failure; Humans; Hypertension; Hypotension, Orthostatic; Indoles; Male; Myocardial Ischemia; Patient Dropouts; Perindopril; Time Factors; Ventricular Dysfunction, Left | 1999 |
[The effect of one-year treatment with captopril on exercise tolerance and myocardial ischemia in patients with myocardial infarction ].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Exercise Tolerance; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia | 2000 |
[Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Topics: Adult; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Platelets; Captopril; Data Interpretation, Statistical; Echocardiography; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Placebos; Time Factors | 2001 |
[Chrono-pharmacodynamics of capoten in patients with ischemic heart disease, postinfarction cardiosclerosis with cardiac failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Chronobiology Phenomena; Female; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Sclerosis | 2001 |
35 other study(ies) available for captopril and Heart Disease, Ischemic
| Article | Year |
|---|---|
Zofenopril: Blood pressure control and cardio-protection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Diuretics; Humans; Hypertension; Myocardial Ischemia | 2022 |
RU28318, an aldosterone antagonist, in combination with an ACE inhibitor and angiotensin receptor blocker attenuates cardiac dysfunction in diabetes.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Heart; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Spironolactone | 2013 |
[Effects of ventricular arrhythmia during early ischemic myocardium with captopril].
Topics: Animals; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Electric Stimulation Therapy; Myocardial Ischemia; Rabbits; Ventricular Fibrillation | 2006 |
Effects of angiotensin-I and ischemia on functional recovery in isolated hearts.
Topics: Analysis of Variance; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Male; Models, Animal; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Wistar; Recovery of Function; Time Factors | 2011 |
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Heart Rate; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar | 2004 |
Letter by Krop et al regarding article, "Role of p90 ribosomal S6 kinase-mediated prorenin-converting enzyme in ischemic and diabetic myocardium".
Topics: Angiotensin II; Angiotensinogen; Animals; Anti-Arrhythmia Agents; Buffers; Captopril; Diabetes Complications; Diabetes Mellitus, Experimental; Diffusion; Free Radical Scavengers; Imidazoles; Kallikreins; Mice; Mice, Transgenic; Myocardial Ischemia; Myocardium; Perfusion; Rats; Renin-Angiotensin System; Ribosomal Protein S6 Kinases, 90-kDa; Species Specificity; Tetrazoles | 2006 |
Effect of captopril on postischemic myocardial expansion.
Topics: Animals; Captopril; Dogs; Female; Heart; Hemodynamics; Infusions, Intravenous; Male; Myocardial Ischemia; Myocardial Reperfusion | 1993 |
Captopril cardioplegia on myocardial protection in the hypertrophied rat hearts.
Topics: Animals; Captopril; Coronary Circulation; Creatine Kinase; Heart Arrest, Induced; Hypertrophy, Left Ventricular; In Vitro Techniques; Lactates; Lactic Acid; Male; Models, Cardiovascular; Myocardial Ischemia; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Renin-Angiotensin System; Ventricular Function, Left | 1994 |
Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Body Weight; Captopril; Dose-Response Relationship, Drug; Hypertrophy, Left Ventricular; Male; Myocardial Ischemia; Organ Size; Rats; Rats, Inbred SHR; Tetrazoles | 1995 |
[The efficacy of isolated ultrafiltration and Capoten in the combined treatment of chronic heart failure].
Topics: Aged; Captopril; Chronic Disease; Combined Modality Therapy; Drug Evaluation; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Ultrafiltration | 1994 |
[Effect of capoten on left diastolic ventricular function in patients with ischemic heart disease complicated with chronic arterial hypertension].
Topics: Adult; Aged; Captopril; Chronic Disease; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Ventricular Function, Left | 1993 |
[Effect of chronic antihypertensive treatment on ischemia-induced lethal ventricular tachyarrhythmias and electrophysiological property in hypertrophied rat hearts].
Topics: Action Potentials; Animals; Captopril; Drug Administration Schedule; Electrophysiology; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Myocardial Ischemia; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tachycardia, Ventricular | 1993 |
Clinical and hemodynamic predictors of survival in patients aged < 65 years with severe congestive heart failure secondary to ischemic or nonischemic dilated cardiomyopathy.
Topics: Adolescent; Adult; Captopril; Cardiomyopathy, Dilated; Child; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Prognosis; Survival Analysis | 1993 |
Deleterious effect of exogenous angiotensin-I on the extent of regional ischaemia and its inhibition by captopril.
Topics: Angiotensin I; Animals; Blood Flow Velocity; Captopril; Coronary Circulation; Dose-Response Relationship, Drug; Male; Myocardial Ischemia; Myocardial Reperfusion; NAD; Organ Culture Techniques; Rabbits; Renin-Angiotensin System | 1993 |
Effect of regression of cardiac hypertrophy on ischemic myocardial damage in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Captopril; Hydralazine; Hypertrophy, Left Ventricular; In Vitro Techniques; Male; Myocardial Ischemia; Myocardial Reperfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1993 |
Cardioprotection in ischemic rat hearts with the SH-containing angiotensin-converting enzyme inhibitor zofenopril: possible involvement of the ATP-sensitive potassium channel.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Vessels; Male; Myocardial Contraction; Myocardial Ischemia; Potassium Channels; Rats; Rats, Inbred WKY; Rats, Sprague-Dawley; Stereoisomerism | 1993 |
Blood pressure and myocardial perfusion in hypertensive patients with and without left ventricular hypertrophy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Captopril; Coronary Circulation; Heart; Heart Rate; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardial Ischemia; Nifedipine; Radiopharmaceuticals; Regression Analysis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1995 |
The release of kininase from rat isolated hearts during myocardial ischaemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Bradykinin; Captopril; Edetic Acid; Hydrogen-Ion Concentration; In Vitro Techniques; Lysine Carboxypeptidase; Male; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Perfusion; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors | 1996 |
Dose-response studies with idrapril in the rat heart during acute myocardial ischaemia and reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Heart; Hydroxylamines; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley | 1996 |
Protective effect of captopril on ischemic myocardium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium-Transporting ATPases; Captopril; Dogs; Hemodynamics; Membrane Proteins; Mitochondria, Heart; Myocardial Ischemia; NAD(P)H Dehydrogenase (Quinone); Oxygen Consumption; Sarcoplasmic Reticulum; Sulfhydryl Compounds | 1997 |
[A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Diabetes Mellitus; Drug Evaluation; Drug Therapy, Combination; Female; Hemodynamics; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Myocardial Ischemia; Ramipril | 1996 |
Beneficial effect of captopril against ischaemia-reperfusion injury in isolated guinea pig hearts.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Calcium Chloride; Captopril; Cardioplegic Solutions; Guinea Pigs; Hemodynamics; In Vitro Techniques; Magnesium; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Perfusion; Potassium Chloride; Sodium Chloride | 1998 |
Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arteriosclerosis; Captopril; Male; Microscopy, Electron, Scanning; Myocardial Ischemia; Myocardium; Obesity; Rats; Rats, Mutant Strains | 1998 |
Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Coronary Circulation; Coronary Vessels; Disease Models, Animal; Dogs; Evaluation Studies as Topic; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Ramipril | 1998 |
[The influence of therapy (sympathomimetic amines versus vasodilators) in the indexes of ejection fraction derived from an analysis of Doppler aortic flow].
Topics: Captopril; Cardiomyopathy, Dilated; Dobutamine; Dopamine; Echocardiography, Doppler; Female; Humans; Hydralazine; Male; Middle Aged; Myocardial Ischemia; Nitroprusside; Pulmonary Wedge Pressure; Stroke Volume; Sympathomimetics; Vascular Resistance; Vasodilator Agents | 1998 |
[Effects of captopril on the myocardial performances and hemodynamics after cardiac arrest].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardioplegic Solutions; Coronary Circulation; Dogs; Female; Heart Arrest, Induced; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Random Allocation; Ventricular Function, Left | 1997 |
EXP3174, the AII antagonist human metabolite of losartan, but not losartan nor the angiotensin-converting enzyme inhibitor captopril, prevents the development of lethal ischemic ventricular arrhythmias in a canine model of recent myocardial infarction.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Captopril; Disease Models, Animal; Dogs; Drug Evaluation, Preclinical; Female; Heart Ventricles; Humans; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardial Ischemia; Tetrazoles; Time Factors | 1999 |
The role of endothelin, protein kinase C and free radicals in the mechanism of the post-ischemic endothelial dysfunction in guinea-pig hearts.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Alkaloids; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Aspartic Acid Endopeptidases; Benzophenanthridines; Bosentan; Captopril; Catalase; Coronary Vessels; Endothelin-Converting Enzymes; Endothelins; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Female; Free Radicals; Glycopeptides; Guinea Pigs; Heart; Losartan; Male; Metalloendopeptidases; Muscle Proteins; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nitroprusside; Oxidative Stress; Phenanthridines; Prazosin; Protein Kinase C; Reactive Oxygen Species; Sulfonamides; Superoxide Dismutase; Tetradecanoylphorbol Acetate; Vasodilator Agents | 2000 |
Cardiac ischemia oxidizes regulatory thiols on ryanodine receptors: captopril acts as a reducing agent to improve Ca2+ uptake by ischemic sarcoplasmic reticulum.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Calcium-Transporting ATPases; Captopril; Cells, Cultured; Dogs; Drug Interactions; Humans; Lipid Peroxidation; Myocardial Ischemia; Oxidation-Reduction; Rabbits; Rats; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Species Specificity; Sulfhydryl Compounds | 2000 |
Captopril and L-arginine have a synergistic cardioprotective effect in ischemic-reperfusion injury in the isolated rat heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Culture Techniques; Drug Therapy, Combination; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Rats; Rats, Wistar | 2000 |
[In contrast to captopril and enalapril, losartan does not increase mortality of gerbils after carotid ligation].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Surgical Procedures; Carotid Arteries; Disease Models, Animal; Enalapril; Gerbillinae; Ligation; Losartan; Myocardial Ischemia; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Survival Analysis | 2001 |
The effect of captopril on nitric oxide formation and on generation of radical forms of mitochondrial respiratory chain compounds in ischemic rat heart.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Coenzymes; Electron Spin Resonance Spectroscopy; Electron Transport; Free Radicals; Iron-Sulfur Proteins; Male; Mitochondria, Heart; Myocardial Ischemia; Nitric Oxide; Oxygen; Rats; Rats, Wistar; Ubiquinone | 2001 |
The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopril; Denervation; Disease Models, Animal; Dose-Response Relationship, Drug; Echocardiography; Heart Failure; Injections, Intra-Arterial; Injections, Intravenous; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Ischemia; Neurons; Paraventricular Hypothalamic Nucleus; Pressoreceptors; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Spironolactone | 2002 |
Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Topics: Adenosine Triphosphate; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Captopril; Creatine Kinase; Hemodynamics; In Vitro Techniques; Lactates; Male; Mitochondria, Heart; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Norepinephrine; Oxidation-Reduction; Phosphocreatine; Rabbits | 1992 |
Combined effect of captopril and aspirin in renal hemodynamics in elderly patients with congestive heart failure.
Topics: Aged; Aspirin; Blood Flow Velocity; Captopril; Creatinine; Drug Therapy, Combination; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kidney Function Tests; Male; Myocardial Ischemia | 1992 |